Transaction · 0001193125-26-237103

Saxena Nishant C

Saxena Nishant C, CBO, reported a transaction classified as grant at Corbus Pharmaceuticals Holdings, Inc. involving 192300.000000 shares for an estimated $0.00. Reported holdings after the transaction were 192300.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACBO
CRBPCorbus Pharmaceuticals Holdings, Inc.
Trade date
May 21, 2026
Filing date
May 22, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded192k$0.00 per share
Holdings after192kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CRBP price since this filing

Daily closing prices, with the filing date and available return windows
CRBP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -9.3%1w ago +5.6%1d ago -14.3%
Returns since7d -30.3%30d -27.2%90d -13.3%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-237103
Stock options (right to buy)
Transaction date
May 21, 2026
Filed May 22, 2026, 08:51 PM · 1d delay
Shares
192,300 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
192,300 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    On May 21, 2026, the Reporting Person was granted 58,300 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the…

  2. F2

    This amount includes 58,300 unvested RSUs granted on May 21, 2026.

  3. F3

    The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on May 21, 2027, with the remaining 75% of the option vesting in eq…

Original filing · 0001193125-26-237103
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CRBP